HSA — authorised 4 February 2022
- Marketing authorisation holder: BIOVERATIV THERAPEUTICS INC
- Status: likely_approved
🇸🇬 Enjaymo in Singapore
HSA authorised Enjaymo on 4 February 2022
Marketing authorisation
Enjaymo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Singapore
Frequently asked questions
Is Enjaymo approved in Singapore?
Yes. HSA authorised it on 4 February 2022.
Who is the marketing authorisation holder for Enjaymo in Singapore?
BIOVERATIV THERAPEUTICS INC holds the Singaporean marketing authorisation.